4.5 Article

Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis

Journal

MEDICAL MICROBIOLOGY AND IMMUNOLOGY
Volume 203, Issue 5, Pages 315-322

Publisher

SPRINGER
DOI: 10.1007/s00430-014-0339-0

Keywords

Toxoplasma; P30 protein; ROP18; Interferon gamma; IL10; Th1; Th2; Peptides; Vaccine

Funding

  1. Colciencias (Colombian Scientific Government Agency) [111351929258]
  2. Universidad Tecnologica de Pereira [5-09-3]

Ask authors/readers for more resources

We determined the specific lymphocyte proliferative response and cytokine profile production regarding Toxoplasma P30 (2017 from virulent and non-virulent strain) and ROP18 protein-derived peptides (from clonal lineages I, II and III) in 19 patients having ocular toxoplasmosis, five suffering chronic asymptomatic infection, nine with congenital toxoplasmosis and eight Toxoplasma negative people. A Beckman Coulter FC500 flow cytometer was used for determining antigen-specific T cells (CD3+ CD4+ or CD3+ CD8+ cells) in peripheral blood culture. IFN gamma and IL10 levels were determined in culture supernatants. Specific CD4+ and CD8+ T cell response to total antigen and P30- and ROP18-derived peptides was observed in infected people. Ocular toxoplasmosis patients had a preferential Th2 response after antigenic stimulation. Non-virulent peptide 2017 was able to shift response toward Th1 in congenitally infected children and virulent peptide 2017 induced a Th2 response in chronically infected, asymptomatic people. An immune response in human toxoplasmosis after ex vivo antigenic stimulation was Th1- or Th2-skewed, depending on a patient's clinical condition. Colombian ocular toxoplasmosis patients' immune response was Th2-skewed, regardless of the nature of antigen stimulus.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Ophthalmology

A new look into uveitis in Colombia: changes in distribution patterns and clinical characteristics over the last 25 years

Diego Polania, Juliana Reyes-Guanes, William Rojas-Carabali, Daniella Pardo-Pizza, Domenico Barraquer-Lopez, Carlos Cifuentes-Gonzalez, Natalia Neira-Segura, Alejandra de-la-Torre

Summary: This study describes the distribution patterns and clinical characteristics of patients diagnosed with uveitis in a specialized uveitis center in Bogota, Colombia, from 2013 to 2021 and compares these patterns with previous reports. The study found a significant shift from infectious etiologies to immune-mediated processes as the cause of uveitis in Colombia.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2023)

Article Ophthalmology

Clinical and Serological Characteristics of Ocular Toxoplasmosis in the Democratic Republic of Congo

Nadine Nsiangani Lusambo, Dieudonne Kaimbo Wa Kaimbo, Dieudonne Mumba Ngoyi, Janvier Kilangalanga Ngoy, Marie-Therese Ngoyi Bambi, Theodore Kadima Mutombo, Guy Kintoki Makela, Lady Ngandowe Nzamokili, Alejandra de-la-Torre

Summary: This study describes demographic data, clinical features, and serological profiles of Congolese patients with ocular toxoplasmosis (OT). The study found that most patients had recurrent OT with multiple, extensive, and central retinochoroidal lesions.

OCULAR IMMUNOLOGY AND INFLAMMATION (2023)

Article Ophthalmology

De Novo Uveitis in the Colombian Elderly Population: Characteristics and Comparison with Patients Under 60 Years of Age

Domenico Barraquer-Lopez, Carlos Cifuentes-Gonzalez, Luisa Fernanda Pena-Pulgar, William Rojas-Carabali, Jeronimo Villa-Pineros, Alejandra de-la-Torre

Summary: This study found significant differences between elderly and young patients with de novo uveitis in Colombia. Idiopathic uveitis was the most common type in the elderly group, followed by immune-mediated and infectious uveitis. Elderly patients had worse visual acuities compared to young patients. There were significant differences between the two groups in corneal edema, macular edema, cataract, glaucoma, and epiretinal membrane. There were also differences in the drugs used.

OCULAR IMMUNOLOGY AND INFLAMMATION (2023)

Letter Ophthalmology

Ocular Inflammation as the First Sign of Relapsing Polychondritis in Hispanic Patients: Report of Three Cases

Jeronimo Villa-Pineros, Mario Ramos-Santodomingo, William Rojas-Carabali, Alejandra de-la-Torre

Summary: This study presents the clinical features, management, and prognosis of three Hispanic patients with ocular involvement as the initial manifestation of RP. It expands the understanding of ocular disease characteristics in RP patients and raises awareness among ophthalmologists, leading to earlier diagnoses and improved treatment for better patient outcomes.

OCULAR IMMUNOLOGY AND INFLAMMATION (2023)

Article Ophthalmology

Risk factors for ocular toxoplasmosis among uveitis patients in Kinshasa, DR Congo

Nadine Nsiangani Lusambo, Dieudonne Kaimbo Wa Kaimbo, Dieudonne Mumba Ngoyi, Pierre Akilimali Zalagile, Alejandra de-la-Torre

Summary: This study aimed to identify the risk factors associated with ocular toxoplasmosis (OT) in a cohort of Congolese patients with uveitis. The results indicated that being under the age of 60, consuming cat meat and undercooked meat, and living in rural areas were identified as risk factors for OT.

BMJ OPEN OPHTHALMOLOGY (2023)

Article Pharmacology & Pharmacy

Adjuvants approved for human use: What do we know and what do we need to know for designing good adjuvants?

Cesar Reyes, Manuel A. Patarroyo

Summary: Adjuvants play a crucial role in vaccine development by allowing the inclusion of previously discarded antigens and expanding the range of candidates. The research on adjuvant development has grown alongside the increasing knowledge of immune systems and their recognition of foreign microorganisms. Although the mechanism of action for alum-derived adjuvants is not fully understood, they have been used in human vaccines for years. The number of adjuvants approved for human use has recently increased, reflecting the efforts to interact with and stimulate the immune system. This review aims to summarize the current understanding of adjuvants, focusing on those approved for human use, their mechanism of action, and their importance in vaccine candidate formulations. The review also discusses the future prospects in this growing research field.

EUROPEAN JOURNAL OF PHARMACOLOGY (2023)

Review Biochemistry & Molecular Biology

Developing Anti-Babesia bovis Blood Stage Vaccines: A New Perspective Regarding Synthetic Vaccines

Laura Cuy-Chaparro, Cesar Reyes, Eliana Vanessa Diaz-Guiot, Darwin Andres Moreno-Perez, Manuel Alfonso Patarroyo

Summary: Bovine babesiosis is a significant tick-borne disease caused by Babesia parasites. Babesia bovis is the most severe species associated with the disease, leading to high economic losses. The traditional approach of using live attenuated vaccines against B. bovis has limitations, prompting researchers to explore alternative methodologies for vaccine production.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Ophthalmology

Ophthalmic manifestations in children with Down Syndrome in Bogota, Colombia

William Rojas-Carabali, Maria Camila Cortes-Albornoz, Gabriela Florez-Esparza, Carlos Cifuentes-Gonzalez, Alejandra de-la-Torre, Claudia Talero-Gutierrez

Summary: This study describes the ocular features of children with Down Syndrome (DS) in Bogota, Colombia. The study evaluated 67 children with DS and found various ophthalmological manifestations such as refractive errors, strabismus, amblyopia, and lens opacity. Gender was associated with strabismus and amblyopia. The study highlights the importance of ophthalmologists and optometrists in assessing and managing visual and ocular problems in children with DS to improve their rehabilitation outcomes.

BMC OPHTHALMOLOGY (2023)

Article Ophthalmology

Colombian Ocular Diseases Epidemiology Study (CODES): incidence and sociodemographic characterisation of keratoconus between 2015 and 2020

German Mejia-Salgado, Carlos Cifuentes-Gonzalez, William Rojas-Carabali, Laura Zarate-Pinzon, Luisa Fernanda Pena-Pulgar, Diego Polania, Danna Lesley Cruz-Reyes, Alejandra de-la-Torre

Summary: This study estimated the incidence of keratoconus (KC) in Colombia using national health registry data. The incidence rate in the general population was 10.36 per 100,000 inhabitants. The disease had a higher incidence in males in their early 20s and females in their late 20s.

BMJ OPEN OPHTHALMOLOGY (2023)

Review Ophthalmology

Immunogenicity of Adalimumab in Patients with Non-Infectious- Uveitis: Systematic Review and Meta-Analysis

Diana Isabel Pachon-Suarez, Laura Zarate-Pinzon, Carlos Cifuentes-Gonzalez, William Rojas-Carabali, German Mejia-Salgado, Juan Sebastian Pineda, Luisa Fernanda Pena-Pulgar, Alejandra de-la-Torre

Summary: This study reviewed the prevalence, incidence, and risk factors for developing anti-drug antibodies (AAA) in patients with non-infectious uveitis (NIU) treated with Adalimumab (ADA). The results showed that the prevalence of AAA in NIU patients treated with ADA is higher in real-life scenarios compared to clinical trials, and several factors are associated with AAA generation in NIU patients.

OCULAR IMMUNOLOGY AND INFLAMMATION (2023)

Review Ophthalmology

Viral Anterior Uveitis: A Practical and Comprehensive Review of Diagnosis and Treatment

Yun Feng, Ruby Garcia, William Rojas-Carabali, Carlos Cifuentes-Gonzalez, Ikhwanuliman Putera, Jingyi Li, Rina La Distia Nora, Padmamalini Mahendradas, Vishali Gupta, Alejandra de-la-Torre, Rupesh Agrawal

Summary: Anterior uveitis is the most common type of uveitis globally, with infectious and non-infectious causes. Common viral pathogens include Herpes Simplex Virus, while emerging viruses like West Nile Virus can also cause anterior uveitis. Early recognition allows prompt management and reduces ocular complications.

OCULAR IMMUNOLOGY AND INFLAMMATION (2023)

Article Microbiology

Genetic Variations in the Purinergic P2X7 Receptor Are Associated with the Immune Response to Ocular Toxoplasmosis in Colombia

Carlos A. Naranjo-Galvis, Rima Mcleod, Jorge Enrique Gomez-Marin, Alejandra de-la-Torre, Cristian Rocha-Roa, Nestor Cardona, Juan Carlos Sepulveda-Arias

Summary: Ocular toxoplasmosis (OT) is characterized by inflammation within the eye. This study identified a significant association between the Gln460Arg single-nucleotide polymorphism (SNP) in the P2RX7 gene and OT in Colombian patients. This SNP could potentially serve as a biomarker for identifying Colombian patients at risk of OT.

MICROORGANISMS (2023)

Article Infectious Diseases

In Vitro Antifungal Activity of Three Synthetic Peptides against Candida auris and Other Candida Species of Medical Importance

Richar Torres, Adriana Barreto-Santamaria, Gabriela Arevalo-Pinzon, Carolina Firacative, Beatriz L. Gomez, Patricia Escandon, Manuel Alfonso Patarroyo, Julian E. Munoz

Summary: The study evaluated the antifungal activity of three synthetic antimicrobial peptides (AMPs) against Candida species, including the multidrug-resistant Candida auris. The AMPs showed antifungal activity against all Candida species tested and had effects on biofilm formation and cell viability in C. auris and C. albicans. The study suggests that these AMPs are potential therapeutic alternatives against important Candida species.

ANTIBIOTICS-BASEL (2023)

Review Multidisciplinary Sciences

Spectrum of ophthalmic manifestations in monkeypox virus infection worldwide: Systematic review and meta-analysis

William Rojas-Carabali, Carlos Cifuentes-Gonzalez, Rupesh Agrawal, Alejandra de-la-Torre

Summary: Mpox virus infection is a global public health concern with potential severity and outbreaks across regions. Ophthalmic manifestations, such as conjunctivitis and periocular umbilicated lesions, are the most common, with potential severe manifestations including corneal opacity. Antiviral treatment and topical management for conjunctivitis can be considered for severe cases, but the evidence quality is poor. Early diagnosis and timely treatment are important for ophthalmologists and healthcare professionals.

HELIYON (2023)

Article Ophthalmology

Clinical characterization of patients with HLA-B27-associated uveitis and evaluation of the impact of systemic treatment on the recurrence rate: a cross-sectional study

Juan Sebastian Pineda-Sierra, Carlos Cifuentes-Gonzalez, William Rojas-Carabali, Paula Tatiana Munoz-Vargas, Alejandro Henao-Posada, Alejandra de-la-Torre

Summary: This study described the clinical characteristics of HLA-B27-associated uveitis in a cohort of Colombian patients and evaluated the impact of systemic treatment on the recurrence rate. The results showed that Colombian patients with HLA-B27-associated uveitis had a higher proportion of females and were older at presentation. Topical corticosteroids, NSAIDs, and DMARDs were commonly used treatments, and the use of DMARDs was associated with a decreased recurrence rate.

JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION (2023)

No Data Available